<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34175230</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-499X</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Trends in molecular medicine</Title><ISOAbbreviation>Trends Mol Med</ISOAbbreviation></Journal><ArticleTitle>Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.</ArticleTitle><Pagination><StartPage>895</StartPage><EndPage>906</EndPage><MedlinePgn>895-906</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.molmed.2021.06.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1471-4914(21)00134-9</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can cause chronic and acute disease. Postacute sequelae of SARS-CoV-2 infection (PASC) include injury to the lungs, heart, kidneys, and brain that may produce a variety of symptoms. PASC also includes a post-coronavirus disease 2019 (COVID-19) syndrome ('long COVID') with features that can follow other acute infectious diseases and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Here we summarize what is known about the pathogenesis of ME/CFS and of 'acute' COVID-19, and we speculate that the pathogenesis of post-COVID-19 syndrome in some people may be similar to that of ME/CFS. We propose molecular mechanisms that might explain the fatigue and related symptoms in both illnesses, and we suggest a research agenda for both ME/CFS and post-COVID-19 syndrome.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Komaroff</LastName><ForeName>Anthony L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Division of General Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: anthony_komaroff@hms.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipkin</LastName><ForeName>W Ian</ForeName><Initials>WI</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY, USA. Electronic address: wil2001@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 AI138370</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trends Mol Med</MedlineTA><NlmUniqueID>100966035</NlmUniqueID><ISSNLinking>1471-4914</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="N">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009420" MajorTopicYN="N">Nervous System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">postacute sequelae of SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">post&#x2013;COVID-19 syndrome</Keyword></KeywordList><CoiStatement>Declaration of interests The authors have no interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>27</Day><Hour>20</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34175230</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pii">S1471-4914(21)00134-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>You J., et al. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge. J. Infect. 2020;81:e150&#x2013;e152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273134</ArticleId><ArticleId IdType="pubmed">32512021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D., et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5:1281&#x2013;1285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L., et al. AKI in hospitalized patients with COVID-19. J. Am. Soc. Nephrol. 2021;32:151&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894657</ArticleId><ArticleId IdType="pubmed">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., et al. Microvascular injury in the brains of patients with Covid-19. N. Engl. J. Med. 2021;384:481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanculescu D., et al. Hypothesis: mechanisms that prevent recovery in prolonged ICU patients also underlie myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front. Med. (Lausanne) 2021;8:628029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876311</ArticleId><ArticleId IdType="pubmed">33585528</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones J.F., et al. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann. Intern. Med. 1985;102:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2578266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wray B.B., et al. Detection of Epstein-Barr virus and cytomegalovirus in patients with chronic fatigue. Ann. Allergy. 1993;71:223&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">8396863</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J. Clin. Virol. 2006;37:S39&#x2013;S46.</Citation><ArticleIdList><ArticleId IdType="pubmed">17276367</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein L., et al. Post-Ebola signs and symptoms in U.S. survivors. N. Engl. J. Med. 2015;373:2484&#x2013;2486.</Citation><ArticleIdList><ArticleId IdType="pubmed">26672870</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar J.J., et al. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J. Neuropsychol. 2008;2:477&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pubmed">19824176</ArticleId></ArticleIdList></Reference><Reference><Citation>Seet R.C., et al. Post-infectious fatigue syndrome in dengue infection. J. Clin. Virol. 2007;38:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17137834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I., et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333:575&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal L.H. Summary of the first 100 patients seen at a Lyme disease referral center. Am. J. Med. 1990;88:577&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">2346158</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia J.K., Chia A.Y. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J. Clin. Pathol. 2008;61:43&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">17872383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr J.R., et al. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J. Gen. Virol. 2010;91:893&#x2013;897.</Citation><ArticleIdList><ArticleId IdType="pubmed">20007355</ArticleId></ArticleIdList></Reference><Reference><Citation>Salit I.E. Sporadic postinfectious neuromyasthenia. CMAJ. 1985;133:659&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1346266</ArticleId><ArticleId IdType="pubmed">4042036</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;rch K., et al. Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course. BMC Gastroenterol. 2013;13:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3598369</ArticleId><ArticleId IdType="pubmed">23399438</ArticleId></ArticleIdList></Reference><Reference><Citation>Eveng&#xe5;rd B., et al. Increased number of Candida albicans in the faecal microflora of chronic fatigue syndrome patients during the acute phase of illness. Scand. J. Gastroenterol. 2007;42:1514&#x2013;1515.</Citation><ArticleIdList><ArticleId IdType="pubmed">17886123</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons G., et al. Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science. 2011;334:814&#x2013;817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3299483</ArticleId><ArticleId IdType="pubmed">21940862</ArticleId></ArticleIdList></Reference><Reference><Citation>Alter H.J., et al. A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus. mBio. 2012;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448165</ArticleId><ArticleId IdType="pubmed">22991430</ArticleId></ArticleIdList></Reference><Reference><Citation>Eveng&#xe5;rd B., et al. Absence of evidence of Borna disease virus infection in Swedish patients with chronic fatigue syndrome. J. Neurovirol. 1999;5:495&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pubmed">10568886</ArticleId></ArticleIdList></Reference><Reference><Citation>Poskanzer D.C., et al. Epidemic neuromyasthenia; an outbreak in Punta Gorda, Florida. N. Engl. J. Med. 1957;257:356&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">13464939</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D., et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. 2017;5:44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5405467</ArticleId><ArticleId IdType="pubmed">28441964</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux L., et al. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. 2016;4:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4918027</ArticleId><ArticleId IdType="pubmed">27338587</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano A.H., et al. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J. Clin. Invest. 2020;130:1491&#x2013;1505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M., et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci. Adv. 2015;1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4465185</ArticleId><ArticleId IdType="pubmed">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya J.G., et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc. Natl. Acad. Sci. U. S. A. 2017;114:E7150&#x2013;E7158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F., et al. Myalgic encephalomyelitis/chronic fatigue syndrome - evidence for an autoimmune disease. Autoimmun. Rev. 2018;17:601&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I., et al. The psychiatric status of patients with the chronic fatigue syndrome. Br. J. Psychiatry. 1990;156:534&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">2386862</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M.E., et al. Treatment of myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review for a National Institutes of Health Pathways to Prevention workshop. Ann. Intern. Med. 2015;162:841&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">26075755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M.A., et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Baral R., et al. COVID-19: a pan-organ pandemic. Oxf. Med. Case Rep. 2020;2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7720417</ArticleId><ArticleId IdType="pubmed">33304597</ArticleId></ArticleIdList></Reference><Reference><Citation>Topol E.J. COVID-19 can affect the heart. Science. 2020;370:408&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">32967937</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n Casas C., et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br. J. Dermatol. 2020;183:71&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267236</ArticleId><ArticleId IdType="pubmed">32348545</ArticleId></ArticleIdList></Reference><Reference><Citation>Koralnik I.J., Tyler K.L. COVID-19: a global threat to the nervous system. Ann. Neurol. 2020;88:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300753</ArticleId><ArticleId IdType="pubmed">32506549</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., et al. Loss of smell and taste in 2013 European patients with mild to moderate COVID-19. Ann. Intern. Med. 2020;173:672&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7505100</ArticleId><ArticleId IdType="pubmed">32449883</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7:875&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., et al. High-dimensional characterization of post-acute sequalae of COVID-19. Nature. 2021 doi: 10.1038/s41586-021-03553-9. Published online April 22, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta E.M., et al. Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann. Clin. Transl. Neurol. 2020;7:2221&#x2013;2230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Sanchez C.M., et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95:e1060&#x2013;e1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Nannoni S., et al. Stroke in COVID-19: a systematic review and meta-analysis. Int. J. Stroke. 2021;16:137&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859578</ArticleId><ArticleId IdType="pubmed">33103610</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridman S., et al. Stroke risk, phenotypes, and death in COVID-19: systematic review and newly reported cases. Neurology. 2020;95:e3373&#x2013;e3385.</Citation><ArticleIdList><ArticleId IdType="pubmed">32934172</ArticleId></ArticleIdList></Reference><Reference><Citation>Uncini A., et al. Guillain-Barr&#xe9; syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic. J. Neurol. Neurosurg. Psychiatry. 2020;91:1105&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">32855289</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheidl E., et al. Guillain-Barr&#xe9; syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. J. Peripher. Nerv. Syst. 2020;25:204&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273104</ArticleId><ArticleId IdType="pubmed">32388880</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon I.H., et al. Neuropathological features of Covid-19. N. Engl. J. Med. 2020;383:989&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., et al. Microvascular injury in the brains of patients with Covid-19. N. Engl. J. Med. 2020;384:481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2020;24:168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann D.H., et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 2020;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann B., et al. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms. J. Neurol. Sci. 2020;418:117090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417278</ArticleId><ArticleId IdType="pubmed">32805440</ArticleId></ArticleIdList></Reference><Reference><Citation>Lersy F., et al. Cerebrospinal fluid features in COVID-19 patients with neurologic manifestations: correlation with brain MRI findings in 58 patients. J. Infect. Dis. 2020;223:600&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7798956</ArticleId><ArticleId IdType="pubmed">33249438</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P., L&#xfc;scher T. COVID-19 is, in the end, an endothelial disease. Eur. Heart J. 2020;41:3038&#x2013;3044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470753</ArticleId><ArticleId IdType="pubmed">32882706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapasi A., Schneider J.A. Vascular contributions to cognitive impairment, clinical Alzheimer&#x2019;s disease, and dementia in older persons. Biochim. Biophys. Acta. 2016;1862:878&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11062590</ArticleId><ArticleId IdType="pubmed">26769363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020;297:E242&#x2013;E251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301613</ArticleId><ArticleId IdType="pubmed">32544034</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x2018;long haulers.&#x2019;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate health care systems network &#x2013; United States, March&#x2013;June 2020. MMWR Morb. Mortal. Wkly Rep. 2020;69:993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J. Infect. 2020;81:e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K., et al. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2020;76:405&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., et al. Persistent symptoms 3&#x202f;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv. 2021 doi: 10.1101/2020.12.24.20248802. Published online April 5, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y., et al. Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an (1)(1)C-(R)-PK11195 PET study. J. Nucl. Med. 2014;55:945&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C., et al. Evidence of widespread metabolite abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. 2020;14:562&#x2013;572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612467</ArticleId><ArticleId IdType="pubmed">30617782</ArticleId></ArticleIdList></Reference><Reference><Citation>Felger J.C. Imaging the role of inflammation in mood and anxiety-related disorders. Curr. Neuropharmacol. 2018;16:533&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5997866</ArticleId><ArticleId IdType="pubmed">29173175</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.L.M.C., et al. Cerebral blood flow is reduced in severe myalgic encephalomyelitis/chronic fatigue syndrome patients during mild orthostatic stress testing: an exploratory study at 20 degrees of head-up tilt testing. Healthcare (Basel) 2020;8:169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349207</ArticleId><ArticleId IdType="pubmed">32545797</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M., et al. Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with chronic fatigue syndrome. Brain Behav. Immun. 2016;52:32&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii H., et al. Altered structural brain networks related to adrenergic/muscarinic receptor autoantibodies in chronic fatigue syndrome. J. Neuroimaging. 2020;30:822&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pubmed">32609410</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld Y., et al. Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. Clin. Immunol. 2020;214:108384.</Citation><ArticleIdList><ArticleId IdType="pubmed">32171889</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux R.K. Metabolic features and regulation of the healing cycle &#x2013; a new model for chronic disease pathogenesis and treatment. Mitochondrion. 2019;46:278&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">30099222</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa-Mattioli M., Walter P. The integrated stress response: from mechanism to disease. Science. 2020;368</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8997189</ArticleId><ArticleId IdType="pubmed">32327570</ArticleId></ArticleIdList></Reference><Reference><Citation>Saper C.B., Machado N.L.S. Flipping the switch on the body&#x2019;s thermoregulatory system. Nature. 2020;583:34&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">32601488</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon D.C., et al. Sickness: from the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons. Neurosci. Biobehav. Rev. 2015;57:30&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">26363665</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B., et al. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. U. S. A. 2021 In press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipkin W.I. Microbe hunting. Microbiol. Mol. Biol. Rev. 2010;74:363&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2937520</ArticleId><ArticleId IdType="pubmed">20805403</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldstone M.B. Viruses can cause disease in the absence of morphological evidence of cell injury: implication for uncovering new diseases in the future. J. Infect. Dis. 1989;159:384&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">2644376</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik U.R., et al. Interferon-mediated fatigue. Cancer. 2001;92:1664&#x2013;1668.</Citation><ArticleIdList><ArticleId IdType="pubmed">11598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine A.D., et al. Mood and cognitive side effects of interferon-alpha therapy. Semin. Oncol. 1998;25:39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">9482539</ArticleId></ArticleIdList></Reference><Reference><Citation>Getts D.R., et al. Virus infection, antiviral immunity, and autoimmunity. Immunol. Rev. 2013;255:197&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3971377</ArticleId><ArticleId IdType="pubmed">23947356</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021 doi: 10.1038/s41586-021-03631-y. Published online May 19, 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin. Med. (Lond) 2021;21:e63&#x2013;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M.J., et al. Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysis. Medicine (Baltimore) 2019;98</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6824690</ArticleId><ArticleId IdType="pubmed">31651868</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., et al. Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients. J. Transl. Med. 2020;18:314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429890</ArticleId><ArticleId IdType="pubmed">32799889</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A., L, B. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front. Med. 2021;7:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine (US), et al. National Academies Press; 2015. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness.</Citation><ArticleIdList><ArticleId IdType="pubmed">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler D.M., Summers L.H. The COVID-19 pandemic and the $16 trillion virus. JAMA. 2020;324:1495&#x2013;1496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604733</ArticleId><ArticleId IdType="pubmed">33044484</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher M.A., et al. Plasma cytokines in women with chronic fatigue syndrome. J. Transl. Med. 2009;7:96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2779802</ArticleId><ArticleId IdType="pubmed">19909538</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton-Fitch N., et al. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome. Syst. Rev. 2019;8:279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6857215</ArticleId><ArticleId IdType="pubmed">31727160</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas J.L., et al. Association of T and NK cell phenotype with the diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front. Immunol. 2018;9:1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5954087</ArticleId><ArticleId IdType="pubmed">29867995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos S., et al. Regulatory T, natural killer T and &#x3b3;&#x3b4; T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison. Asian Pac. J. Allergy Immunol. 2016;34:300&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">27001659</ArticleId></ArticleIdList></Reference><Reference><Citation>Milivojevic M., et al. Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373296</ArticleId><ArticleId IdType="pubmed">32692761</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano E., et al. Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Sci. Rep. 2016;6:34990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5057083</ArticleId><ArticleId IdType="pubmed">27725700</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter S.E., Evans A.M. Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity. J. Intern. Med. 2011;270:76&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">21205027</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong C.W., et al. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics. 2015;11:1626&#x2013;1639.</Citation></Reference><Reference><Citation>Missailidis D., et al. An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int. J. Mol. Sci. 2020;21:1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7036826</ArticleId><ArticleId IdType="pubmed">32041178</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C., et al. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function. PLoS One. 2020;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147788</ArticleId><ArticleId IdType="pubmed">32275686</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson N., et al. Elevated energy production in chronic fatigue syndrome patients. J. Nat. Sci. 2016;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065105</ArticleId><ArticleId IdType="pubmed">27747291</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux R.K., et al. Metabolic features of chronic fatigue syndrome. Proc. Natl. Acad. Sci. U. S. A. 2016;113:E5472&#x2013;E5480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J., et al. Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review. Exerc. Immunol. Rev. 2014;20:94&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">24974723</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., et al. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Med. Sci. Monit. 2011;17:SC11&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539515</ArticleId><ArticleId IdType="pubmed">21455120</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson M., et al. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Scand. J. Med. Sci. Sports. 2010;20:282&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">19422646</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa K., Fujita M. Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome. Int. J. Cardiol. 2009;136:238&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">18684522</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenouillet E., et al. Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients. J. Transl. Med. 2016;14:251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5006431</ArticleId><ArticleId IdType="pubmed">27580693</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Maes M. Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) Curr. Neuropharmacol. 2014;12:168&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3964747</ArticleId><ArticleId IdType="pubmed">24669210</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez A., et al. Nitric oxide metabolite production during exercise in chronic fatigue syndrome: a case-control study. J. Women&#x2019;s Health (Larchmt) 2010;19:1073&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">20469961</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B.H., et al. Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity. J. Neurol. Sci. 2017;375:411&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5393352</ArticleId><ArticleId IdType="pubmed">28320179</ArticleId></ArticleIdList></Reference><Reference><Citation>Shungu D.C., et al. Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. 2012;25:1073&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3896084</ArticleId><ArticleId IdType="pubmed">22281935</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockshell S.J., Mathias J.L. Cognitive functioning in chronic fatigue syndrome: a meta-analysis. Psychol. Med. 2010;40:1253&#x2013;1267.</Citation><ArticleIdList><ArticleId IdType="pubmed">20047703</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Oosterwijck J., et al. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study. J. Intern. Med. 2010;268:265&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">20412374</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J., et al. In the mind or in the brain? Scientific evidence for central sensitisation in chronic fatigue syndrome. Eur. J. Clin. Investig. 2012;42:203&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">21793823</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus M., et al. Reduced pressure pain thresholds in response to exercise in chronic fatigue syndrome but not in chronic low back pain: an experimental study. J. Rehabil. Med. 2010;42:884&#x2013;890.</Citation><ArticleIdList><ArticleId IdType="pubmed">20878051</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D., et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann. Intern. Med. 1992;116:103&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pubmed">1309285</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnden L.R., et al. Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome. Neuroimage Clin. 2018;20:102&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309570</ArticleId><ArticleId IdType="pubmed">30497131</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D.B., et al. Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls. Neuroimage. 2007;36:108&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">17408973</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz R.B., et al. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. AJR Am. J. Roentgenol. 1994;162:943&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pubmed">8141022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak L.M., et al. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol. Psychol. 2011;87:183&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">21315796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wortinger L.A., et al. Aberrant resting-state functional connectivity in the salience network of adolescent chronic fatigue syndrome. PLoS One. 2016;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944916</ArticleId><ArticleId IdType="pubmed">27414048</ArticleId></ArticleIdList></Reference><Reference><Citation>Gay C.W., et al. Abnormal resting-state functional connectivity in patients with chronic fatigue syndrome: results of seed and data-driven analyses. Brain Connect. 2016;6:48&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4744887</ArticleId><ArticleId IdType="pubmed">26449441</ArticleId></ArticleIdList></Reference><Reference><Citation>Wylie G.R., et al. Using functional connectivity changes associated with cognitive fatigue to delineate a fatigue network. Sci. Rep. 2020;10:21927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736266</ArticleId><ArticleId IdType="pubmed">33318529</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswal B., et al. Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling. J. Neurol. Sci. 2011;301:9&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3139492</ArticleId><ArticleId IdType="pubmed">21167506</ArticleId></ArticleIdList></Reference><Reference><Citation>Baraniuk J.N., et al. A chronic fatigue syndrome&#x2013;related proteome in human cerebrospinal fluid. BMC Neurol. 2005;5:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1326206</ArticleId><ArticleId IdType="pubmed">16321154</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport T.E., et al. Properties of measurements obtained during cardiopulmonary exercise testing in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Work. 2020;66:247&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">32568145</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D.E., et al. Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study. Eur. J. Clin. Investig. 2012;42:186&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">21749371</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D.B., et al. Neural consequences of post-exertion malaise in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav. Immun. 2017;62:87&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">28216087</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>